Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

ELI-011

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Elicio Therap, Moffitt Cancer Center

Drug class:

CD19-targeted CAR-T immunotherapy, Immunostimulant

Related drugs:

‹

astuprotimut-R (0)

axicabtagene ciloleucel (24)

lisocabtagene maraleucel (23)

tisagenlecleucel-T (15)

brexucabtagene autoleucel (4)

relmacabtagene autoleucel (2)

obecabtagene autoleucel (1)

CAR-T19/CAR-T22 immunotherapy (1)

varnimcabtagene autoleucel (1)

alloCART-19 cell therapy (0)

anti-CD19-CAR (0)

Anti-CD19-CAR (0)

Anti-CD19 CAR-T (0)

anti-CD19 CAR-T cell therapy (0)

anti-CD19 CAR-T cell therapy (0)

anti-CD19 CAR-T therapy (0)

anti-CD19-CAR γδT (0)

anti-CD19/CD22 CAR-T cells (0)

anti-CD19 DASH CAR-T (0)

autologous 3rd generation CD19-targeting CAR T cell therapy (0)

human derived (0)

Autologous CAR-T cells (0)

autologous TriCAR T (0)

CAR19T2 T cells (0)

CAR20.19.22 T (0)

CAR-20/19-T Cells (0)

CARCIK-CD19 (0)

CART-138/BCMA/19/more (0)

CAR-T CD19/CD20/CD22/CD30 (0)

CD19-7×19 CAR-T (0)

CD19 and CD22 targeted prime CAR-T (0)

CD19/BAFF-R dual CAR T (0)

CD19/BCMA targeted CAR T-cells (0)

CD19-CAR.CD45RA- negative T-cells (0)

CD19-CAR-DNT (0)

CD19-CAR_Lenti T cells (0)

CD19-CAR-T2 cells (0)

CD19 CAR T cells (0)

CD19CAR/virus specific T cell therapy (0)

CD19/CD20 CAR T-cells (0)

CD19-CD22 CAR-T (0)

CD19/CD22 CAR T-cells (0)

CD19/CD22 CAR-T cell therapy (0)

CD19/CD22 chimeric antigen receptor T cell (0)

CD19/CD22 dual-target CAR-T (0)

CD19-CD34 CAR transduced T cells (0)

CD19-CD34t metabolically programmed CAR transduced T-cells (0)

CD19/NKG2DL CAR-T Therapeutic (0)

CD19-PD1-CART cell (0)

CD19 targeted CAR-T (0)

CD19-targeted CAR-T cells (0)

CD19 UCART cells (0)

CD19x22 CAR T (0)

CD20-CD19 cCAR T cells (0)

CD22/CD19 CAR T (0)

CLBR001/SWI019 (0)

CMV/CD19 bi-Specific CAR T (0)

CTA30X UCAR-T (0)

DDCAR-CD19 T-cells (0)

EGFRt/19-28z/4-1BBL CAR T cells (0)

huCART19-IL18 (0)

human anti CD19 CAR-T cells (0)

humanized CD19 CAR-T cell therapy (0)

iC9-CAR19 cells (0)

IM19 CAR-T cells (0)

MB-CAR-T19-22 (0)

multi-CAR-T cell therapy (0)

multi-target gene-modified CAR-T/TCR-T cell immunotherapy (0)

murine autologous anti-CD19 CART cells (0)

murine CD19 CAR-T cell therapy (0)

anbalcabtagene autoleucel (0)

RPM CD19-mbIL15-CAR-T cells (0)

SCRI-CAR19x22v2 (0)

SCRI-huCAR19v1 (0)

SCRI-huCAR19v2 (0)

Senl_H19x22P (0)

sequential different B cell antigen-targeted CAR T-cell therapy (0)

SNUH-CD19-CAR-T (0)

STK-009/SYNCAR-001 (0)

ThisCART19A (0)

TriCAR19.20.22 T cells (0)

UCD19 CAR T Cells (0)

XYF19 CAR-T cells (0)

inaticabtagene autoleucel (0)

MB-CART2019.1 (0)

MB-CART 19.1 (0)

tirvalimogene teraplasmid (2)

Histone H3.3-K27M Neoantigen Vaccine Therapy (1)

sipuleucel-T (1)

Versamune HPV (1)

aDC1 vaccine (0)

Ad-CCL21-DC (0)

AdHER2/neu DC Vaccine (0)

allogeneic K562-GM tumor cell vaccine (0)

allogeneic Myeloma GM-CSF Vaccine (0)

bioengineered allogeneic immune cells (0)

velimogene aliplasmid (0)

alpha-lactalbumin vaccine (0)

APVAC1 vaccine (0)

autologous Tcm cellular immunotherapy (0)

BCG vaccine (0)

interferon alpha 2b (0)

dasiprotimut-T (0)

BN-Brachyury (0)

CD25hi Treg depleted DLI (0)

Escherichia coli (0)

recombinant human papillomavirus bivalent vaccine (0)

dendritic cell vaccine (0)

cancer vaccine MUC-1 (0)

DC-AdGMCAIX (0)

autologous dendritic cell vaccine leaded with autologous tumor cell lysate (0)

Dendritic cell renal cell carcinoma fusion vaccine (0)

DNAJB1-PRKACA peptide vaccine (0)

EP-101 STEMVAC (0)

FR Alpha Peptide Vaccine (0)

Fusion-VAC-XS15 (0)

human papillomavirus 9-valent vaccine, recombinant (0)

types 6, 11, 16, 18 (0)

gp96-Ig vaccine (0)

GSK2130579A (0)

GSK2302032A (0)

GVAX leukemia vaccine (0)

GVAX lung cancer vaccine (0)

H1299 cell lysate with iscomatrix adjuvant vaccine (0)

H1299 lung cancer cell lysate vaccine with Montanide ISA-51 VG adjuvant (0)

HER2- and HER3-primed dendritic cells (0)

HER-2 pulsed DC1 (0)

HRXG-K-1939 (0)

IDH1R132H peptide vaccine (0)

autologous γδ T lymphocytes (0)

iNeo-Vac-P01 (0)

iNeo-Vac-R01 (0)

KRAS peptide vaccine (0)

axalimogene filolisbac (0)

mammaglobin-A DNA vaccine (0)

autologous dendritic cell vaccine (0)

multi-epitope melanoma peptide (0)

MVA-BN-Brachyury IV vaccine (0)

neoantigen DNA vaccine (0)

neoantigen peptide vaccine (0)

NEO_PLIN2101 (0)

nonavalent HPV vaccine (0)

NUMARZU-001 (0)

NY-ESO-1 combined with MPLA vaccine (0)

NY-ESO-1 Iscomatrix (0)

ruxotemitide (0)

oral therapeutic vaccine V3-X (0)

p.DOM-WT1-126 DNA vaccine (0)

PEG IFN-a 2b (0)

PF-06753512 (0)

PF-07263689 (0)

pING-hHER3FL (0)

PNV21 vaccine (0)

Poly-ICLC matured DC adjuvanted NY-ESO-1/Melan-A-MART-1 peptide vaccine (0)

PolyPEPI 1018 (0)

polyvalent vaccine-KLH conjugate (0)

rilimogene galvacirepvec (0)

HSP Gp96 vaccine (0)

RNA-NP vaccine (0)

self-amplifying RNA cancer vaccine (0)

BCG vaccine (0)

SQZ-PBMC-HPV (0)

EGFREDVmiR-16 (0)

TG01 vaccine (0)

live attenuated bacillus Calmette-Guerin (0)

CMV-MVA vaccine (0)

TVI-Brain-1 (0)

Undisclosed ovarian cancer vaccine (0)

Undisclosed VLP vaccine (0)

alpha-tocopheroloxyacetic acid (0)

VV-GMCSF-Lact (0)

astuprotimut-R (0)

›